Abel Hall LLC Acquires 194 Shares of Sanofi (NASDAQ:SNY)

Abel Hall LLC boosted its stake in shares of Sanofi (NASDAQ:SNY) by 1.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 10,990 shares of the company’s stock after acquiring an additional 194 shares during the quarter. Abel Hall LLC’s holdings in Sanofi were worth $530,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Synergy Asset Management LLC acquired a new position in shares of Sanofi during the fourth quarter valued at $25,000. Manning & Napier Advisors LLC boosted its stake in shares of Sanofi by 4.7% in the 4th quarter. Manning & Napier Advisors LLC now owns 280,881 shares of the company’s stock valued at $13,547,000 after purchasing an additional 12,688 shares during the last quarter. R Squared Ltd acquired a new stake in shares of Sanofi during the 4th quarter worth approximately $202,000. Capital Investment Counsel LLC raised its stake in shares of Sanofi by 2.2% during the fourth quarter. Capital Investment Counsel LLC now owns 67,958 shares of the company’s stock worth $3,278,000 after buying an additional 1,471 shares during the last quarter. Finally, Patriot Financial Group Insurance Agency LLC lifted its holdings in Sanofi by 13.6% in the fourth quarter. Patriot Financial Group Insurance Agency LLC now owns 23,882 shares of the company’s stock valued at $1,152,000 after buying an additional 2,857 shares during the period. Institutional investors and hedge funds own 14.04% of the company’s stock.

Analyst Ratings Changes

Separately, StockNews.com lowered shares of Sanofi from a “buy” rating to a “hold” rating in a report on Thursday, December 12th.

Sanofi Price Performance

Sanofi stock opened at $52.37 on Thursday. The company has a current ratio of 1.00, a quick ratio of 0.65 and a debt-to-equity ratio of 0.17. The firm has a market capitalization of $132.92 billion, a P/E ratio of 26.72, a PEG ratio of 1.19 and a beta of 0.57. The business has a 50-day moving average of $48.99 and a 200-day moving average of $52.22. Sanofi has a 1 year low of $45.22 and a 1 year high of $58.97.

Sanofi (NASDAQ:SNY) last issued its quarterly earnings data on Thursday, January 30th. The company reported $0.70 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.70. Sanofi had a net margin of 9.96% and a return on equity of 27.45%. On average, equities analysts anticipate that Sanofi will post 3.82 EPS for the current year.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.